Vaxart Approved by BARDA to Start Dosing in Phase...
Category : Clinical Trial Update 19 May 2025Vaxart, Inc, a clinical-stage biotechnology company developing a range of oral recombinant vaccines...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Foresee Starts Phase 2 WINDWARD Trial of Mirivadel...
Category : Clinical Trial Update 19 May 2025Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company, announced the dosing of th...
Gene Solutions, NEWCL Partner to Boost Genetic Tes...
Category : Licensing/Collaboration Deal 19 May 2025In a groundbreaking move, Gene Solutions, a leader in prenatal and oncology genetic testing, and NEW...
Rein Therapeutics Begins Phase 2 RENEW Trial of LT...
Category : Clinical Trial Update 14 May 2025Rein Therapeutics (Rein), a biopharmaceutical company advancing a novel pipeline of first-in-class m...
Trixeo Aerosphere Approved in UK with Eco-Friendly...
Category : Approval/Launch 14 May 2025AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF), alread...
Latest Newsletter Post
-
Gene Solutions, NEWCL Partner to Bo..
19 May 2025
-
Foresee Starts Phase 2 WINDWARD Tri..
19 May 2025
-
Vaxart Approved by BARDA to Start D..
19 May 2025
-
ABLi Therapeutics Launches with Nov..
14 May 2025
-
Trixeo Aerosphere Approved in UK wi..
14 May 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com